Publications & Works

Publication Network
Journal articles indexed in SCI, SSCI, and AHCI

The relationships between fear of cancer recurrence, spiritual well-being and psychological resilience in non-metastatic breast cancer survivors during the COVID-19 outbreak

KORAL L., ÇIRAK Y.
PSYCHO-ONCOLOGY , vol.30, no.10, pp.1765-1772, 2021 (SCI-Expanded) Sustainable Development identifier identifier identifier

HIGH LIPOCALIN-2 EXPRESSION INCREASES PEMETREXED SENSITIVITY IN PATIENTS WITH LUNG ADENOCARCINOMA

AHÇI S., ÇIRAK Y., ADALI Y.
ACTA MEDICA MEDITERRANEA , vol.37, no.1, pp.495-500, 2021 (SCI-Expanded) identifier identifier

Hormone receptor status and survival of medullary breast cancer patients

Aksoy A., ODABAS H., Kaya S., BOZKURT O., DEGIRMENCI M., Topcu T. O., et al.
SAUDI MEDICAL JOURNAL , vol.38, no.2, pp.156-162, 2017 (SCI-Expanded) Sustainable Development identifier identifier identifier

Benign metastasizing leiomyoma of bone and lung in postmenopausal women: two rare case reports and review of the literature

Cirak Y., SEVER O. N., URUN Y.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.38, no.1, pp.118-121, 2017 (SCI-Expanded) Sustainable Development identifier identifier

THE ALBUMIN-GLOBULIN RATIO PREDICTING MORTALITY IN GASTRIC CARCINOMA

Aksoy A., Durak S., Ozturk T., AVCI N., Cirak Y., Deger A. N., et al.
ACTA MEDICA MEDITERRANEA , vol.32, no.3, pp.707-712, 2016 (SCI-Expanded) Sustainable Development identifier identifier

Aurora A overexpression in breast cancer patients induces taxane resistance and results in worse prognosis

Cirak Y., Furuncuoglu Y., YAPICIER O., Aksu A., CUBUKCU E.
JOURNAL OF BUON , vol.20, no.6, pp.1414-1419, 2015 (SCI-Expanded) Sustainable Development identifier identifier identifier

Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer

Cirak Y., Furuncuoglu Y., Yapicier O., Alici S., Argon A.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY , vol.8, no.5, pp.5345-5353, 2015 (SCI-Expanded) Sustainable Development identifier identifier identifier

Survival analysis of metastatic colorectal cancer patients who were treated with the five major therapeutic agents over the course of disease

Varol U., Cirak Y., ÇAKAR B., KARACA B., Sezgin C., Uslu R., et al.
JOURNAL OF BUON , vol.18, no.3, pp.647-652, 2013 (SCI-Expanded) Sustainable Development identifier identifier identifier

Predictive and prognostic values of Tau and BubR1 protein in prostate cancer and their relationship to the Gleason score

Cirak Y., SARSIK KUMBARACI B., ÇAKAR B., ŞEN S., ŞİMŞİR A., Uslu R.
MEDICAL ONCOLOGY , vol.30, no.2, 2013 (SCI-Expanded) Sustainable Development identifier identifier identifier

Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer

ÇAKAR B., Varol U., Junushova B., Muslu U., Oner P. G., Surmeli Z. G., et al.
JOURNAL OF BUON , vol.18, no.2, pp.372-376, 2013 (SCI-Expanded) Sustainable Development identifier identifier identifier

Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A

Cirak Y., Varol U., Atmaca H., Kisim A., Sezgin C., KARABULUT B., et al.
BJU INTERNATIONAL , vol.110, 2012 (SCI-Expanded) Sustainable Development identifier identifier identifier

Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer

Degirmenci M., KARACA B., Gorumlu G., DURUSOY ONMUŞ İ. R., PISKIN G. D., BOZKURT M. T., et al.
MEDICAL ONCOLOGY , vol.27, no.3, pp.585-591, 2010 (SCI-Expanded) Sustainable Development identifier identifier identifier

Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells

Atmaca H., Gorumlu G., Karaca B., Degirmenci M., Tunali D., Cirak Y., et al.
EUROPEAN CYTOKINE NETWORK , vol.20, no.3, pp.121-130, 2009 (SCI-Expanded) Sustainable Development identifier identifier identifier

Aspergillus pneumonia in renal transplant recipients at a medical center in Turkey

USTA M., KAHVECIOGLU S., AKDAG I., GULLULU M., OZDEMIR B., ENER B., et al.
TRANSPLANTATION PROCEEDINGS , vol.36, no.9, pp.2703-2707, 2004 (SCI-Expanded) Sustainable Development identifier identifier identifier
Articles Published in Other Journals

Predictive and Prognostic Role of Lipocalin-2 Expression in Prostate Cancer and Its Association with Gleason Score

ULUSOY M. H., ÇIRAK Y., Adali Y.
PROSTATE CANCER , vol.2021, 2021 (ESCI) Sustainable Development identifier identifier

EVALUATION OF TREATMENT RELATED TOXICITIES AND TREATMENT ADHERENCE IN SYRIAN REFUGEES WITH CANCER

NURAY SEVER Ö., PETEKKAYA İ., ÇIRAK Y., ÜRÜN Y.
Acıbadem üniversitesi Sağlık Bilimleri Dergisi , vol.6, no.4, pp.216-219, 2015 (Peer-Reviewed Journal) Sustainable Development

Erkek Genital Sistem Kanserlerinin Moleküler Biyolojisi ve Karsinogenez

ÇIRAK Y., GÖKER E.
Turkiye Klinikleri Journal of Medical Oncology Special Topics , vol.4, no.1, pp.135-147, 2011 (Peer-Reviewed Journal) Sustainable Development

The effect of racemic gossypol and at 101 on angiogenic profile of ovcar 3 cells a preliminary molecular framework for gossypol enantiomers

VAROL U., KARACA Ş. B., TUNALI D., DEĞİRMENCİ M., ÇIRAK Y., PURCU D., et al.
EXPERİMENTAL ONCOLOGY , vol.31, no.4, pp.220-5, 2009 (Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences

COVID-19 Salgını Sırasında Non-Metastatik Meme Kanseri Hastalarında Kanser Nüksetme Korkusu, Manevi İyilik Hali ve Psikolojik Dayanıklılık Arasındaki İlişkilerin Değerlendirilmesi

KORAL L., ÇIRAK Y.
4. ulusal immunoterapi ve onkoloji kongresi, Ankara, Turkey, 29 October 2020, (Full Text) Sustainable Development

Overin matür kistik teratomu zemininde gelişmiş metastatik malign melanom olgusu

ÇIRAK Y., KORAL L.
6. EGE HEMATOLOJİ ONKOLOJİ KONGRESİ 13-15 MART 2020, ÇEŞME / İZMİR, Turkey, 13 May 2020, (Summary Text)

Multipl myelomu taklit eden metaplastik meme kanseri olgusu

ÇIRAK Y., KORAL L.
6. EGE HEMATOLOJİ ONKOLOJİ KONGRESİ 13-15 MART 2020, ÇEŞME / İZMİR, Turkey, 13 March 2020, (Summary Text) Sustainable Development

Predictive value of BubR1 and synuclein- gamma expression in breast cancer.

Cirak Y., FURUNCUOGLU Y., YAPICIER O., ARGON A., ALICI S.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33, (Summary Text) Sustainable Development identifier

Meme kanserinde synuclein gamma ekspresyonunun prediktif değeri

ÇIRAK Y., FURUNCUOĞLU Y., YAPICIER Ö., ÇUBUKCU E., ALICI S., ARGON A.
21. Ulusal kanser kongresi, Turkey, 22 - 26 April 2015 Sustainable Development

Obezite kanser İlişkisi

FURUNCUOĞLU Y., ÇIRAK Y.
Ulusal kanser kongresi, Turkey, 22 - 26 April 2015 Sustainable Development

Meme kanserinde bubr1 ekspresyonu ve taksan direnci

ÇIRAK Y., FURUNCUOĞLU Y., YAPICIER Ö., ARGON A., ALICI S.
21. Ulusal kanser kongresi, Turkey, 22 - 26 April 2015 Sustainable Development

Pozitron emilsiyon tomografi bilgisayarlı tomografi pet bt de çok yoğun florodeoksiglukoz fdg tutan benign adrenal onkositik neoplazm

ÇIRAK Y., SELEK A., GÜL A. E.
21. Ulusal kanser kongresi, Turkey, 22 - 26 April 2015

Cerrahi menopoz sırasında uterin leiomyomanın yaygın akciğer ve kemik metastazları

ÇIRAK Y., FURUNCUOĞLU Y., ONAT E., İYİGÜN Ö., YAPICIER Ö.
21. Ulusal kanser kongresi, Turkey, 22 - 26 April 2015

Prostat kanseri hücre hatlarında zoledronik asit uygulamasının sitotoksik ve anti anjiogenik etkilerinin araştırılması

GÖKALP C., KARACA Ş. B., ÇAKAR B., ÇIRAK Y., KISIM A., ATMACA H., et al.
19. Ulusal Kanser kongresi, Turkey, 20 - 24 April 2011 Sustainable Development

Zoledronik asit in protein fosfataz inhibitörleri ile kombinasyonunun insan hormon refrakter prostat kanser kanseri hücrelerinde farnesilprofosfat sentaz üzerine etkilerinin araştırılması

KARACA Ş. B., ÇIRAK Y., TUNALI D., ÇAKAR B., ATMACA H., KISIM A., et al.
19. Ulusal Kanser kongresi, Turkey, 20 - 24 April 2011 Sustainable Development

İnsan meme kanseri hücre hatlarında AT 101 trail kombinasyonunun sitotoksik ve apoptotik etkilerinin araştırılması

ÇAKAR B., KISIM A., KARACA Ş. B., ÇIRAK Y., ATMACA H., UZUNOĞLU S., et al.
VII. Ulusal Tıbbi Onkoloji Kongres, Turkey, 22 - 26 September 2010 Sustainable Development

AT 101 Cisplatin kombinasyonunun insan over kanseri hücre hatları üzerindeki olası sinerjistik sitotoksik ve apoptotik etkilerinin araştırılması

KARACA Ş. B., GÖRÜMLÜ G., DEĞİRMENCİ M., TUNALI D., VAROL U., ÇIRAK Y., et al.
6. Ulusal Tıbbi Onkoloji Kongresi, Turkey, 24 - 28 September 2009 Sustainable Development

Dosetaksel octreotid kombinasyonunun prostat kanseri hücre hatlarında apoptotik proteinler üzerindeki etkilerinin araştırılması

VAROL U., KARACA Ş. B., GÖRÜMLÜ G., DEĞİRMENCİ M., TUNALI D., ÇIRAK Y., et al.
6. Ulusal Tıbbi Onkoloji Kongresi, Turkey, 24 - 28 September 2009 Sustainable Development

The comparison of total and free PSA and free to total PSA ratios in hemodialysis and CAPD patients

ERSOY A., YAVUZ M., GÜLLÜLÜ M., ÇIRAK Y., ASLANHAN İ., DİLEK K., et al.
XXXVII Congress of the European Renal Association European Dialysis and Transplant Association First combined congress with European Kidney Research Association, 17 - 20 September 2000, (Summary Text)

Güney Marmara yöresindeki mide kanserli olguların epidemiyolojik özellikleri

GÜLTEN M., NAK S. G., DOLAR M. E., KARAARSLAN Y., KILIÇTURGAY S. A., ÇIRAK Y., et al.
13.Ulusal Gastroenteroloji Kongresi, Turkey, 8 - 13 October 1996 Sustainable Development
Metrics

Publication

34

Citation (WoS)

180

H-Index (WoS)

9

Citation (Scopus)

189

H-Index (Scopus)

9

Project

2
UN Sustainable Development Goals